The Kavita and Lalit Bahl Center for Metabolomics and Imaging is Stony Brook Cancer Center’s one-of-a-kind metabolomics and imaging translational research program. It capitalizes on Stony Brook University’s expertise in three major areas – cancer research and treatment, imaging and metabolomics – to address one of the last critical frontiers in cancer research: metabolomics and lipidomics.
The Bahl Center is transforming precision-based cancer care. By combining Stony Brook’s unique strengths in the basic sciences, applied mathematics and high performance computing with the human capital of its physicians and scientists, the center is driving research in body chemistry, diagnostics, therapeutics, intervention and prevention.
The result of the center's collective work will lead to more individualized care, earlier detection through identification of biomarkers, new treatment targets and more precise monitoring of treatment response. As these research breakthroughs are realized, public health policies can be shaped to better facilitate cancer prevention practices.